No Data
TerrAscend to Participate in the ATB Capital Markets 2024 Life Sciences Institutional Investor Conference on September 18th in NYC
Cannabis Stocks Drop as DEA Sets Drug-rescheduling Hearing After November Election
Craig-Hallum Keeps Their Buy Rating on TerrAscend Corp (TSND)
Buy Rating on TerrAscend Corp. Amidst Favorable Political Shifts and Strategic Financial Strengths
TerrAscend Corp (TSND) Receives a Hold From Needham
TerrAscend Cuts Its Q2 Loss In Half And Says It Is Moving To Expand Its Geographic Footprint
No Data